Perceptive Advisors LLC Fusion Pharmaceuticals Inc. Transaction History

Perceptive Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$7.9 - $21.32 $32.2 Million - $86.9 Million	4,074,000 Added 148.07%	6,825,395 $146 Million
Q2 2023 Aug 14, 2023	SELL	$3.47 - $5.33 $29,637 - $45,523	-8,541 Reduced 0.31%	2,751,395 $12.8 Million
Q1 2023 May 15, 2023	BUY	$3.03 - $5.13 $8.36 Million - $14.2 Million	2,759,936 New	2,759,936 $10.4 Million
Q2 2022 Aug 15, 2022	SELL	$2.49 - $7.86 $434,684 - $1.37 Million	-174,572 Reduced 14.23%	1,052,445 $2.62 Million
Q4 2021 Feb 14, 2022	SELL	$4.17 - $7.78 $115,050 - $214,650	-27,590 Reduced 2.2%	1,227,017 $5.12 Million
Q3 2021 Nov 15, 2021	SELL	$7.83 - $9.41 $4.08 Million - $4.9 Million	-520,560 Reduced 29.32%	1,254,607 $9.94 Million
Q2 2021 Aug 16, 2021	SELL	$7.97 - $10.66 $1.39 Million - $1.87 Million	-175,000 Reduced 8.97%	1,775,167 $14.3 Million
Q1 2021 May 17, 2021	SELL	$9.75 - $13.09 $2.79 Million - $3.74 Million	-285,816 Reduced 12.78%	1,950,167 $20.9 Million
Q2 2020 Aug 14, 2020	BUY	$17.0 - $17.78 $38 Million - $39.8 Million	2,235,983 New	2,235,983 $36 Million

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.